Literature DB >> 23021242

Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds.

William S M Wold1, Karoly Toth.   

Abstract

The Syrian (golden) hamster (Mesocricetus auratus) has served as a useful model for different aspects of biology for at least 50 years, and its use has been expanding recently. In earlier years, among other things, it was a model for cancer development. More recently, it has become a model for many different infectious diseases. It has also become an alternative model for the study of oncolytic adenovirus vectors for cancer gene therapy. Among several other human pathogens, the hamster is permissive for the replication of human species C adenoviruses, which are the parental virus for the majority of adenovirus vectors in use today. These vectors replicate in some of the established hamster tumor cell lines that can be used to generate tumors in vivo, that is, one can study oncolytic (replication competent) adenoviruses in a permissive, immunocompetent model. This has afforded the opportunity to study the effect of the host immune system on the vector-infected tumor and has allowed the use of a more relevant animal model to determine the safety and biodistribution of replication-competent adenoviruses. The hamster has also been used to evaluate antiviral compounds and vaccines against many viruses, including adenoviruses, flaviviruses, alphaviruses, arenaviruses, bunyaviruses, and paramyxoviruses.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23021242     DOI: 10.1016/B978-0-12-398342-8.00003-3

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  36 in total

1.  Evaluation of the HC-04 cell line as an in vitro model for mechanistic assessment of changes in hepatic cytochrome P450 3A during adenovirus infection.

Authors:  Piyanuch Wonganan; Kristina Jonsson-Schmunk; Shellie M Callahan; Jin Huk Choi; Maria A Croyle
Journal:  Drug Metab Dispos       Date:  2014-04-24       Impact factor: 3.922

Review 2.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Production of Genetically Engineered Golden Syrian Hamsters by Pronuclear Injection of the CRISPR/Cas9 Complex.

Authors:  Rong Li; Jinxin Miao; Zhiqiang Fan; SeokHwan Song; Il-Keun Kong; Yaohe Wang; Zhongde Wang
Journal:  J Vis Exp       Date:  2018-01-09       Impact factor: 1.355

4.  USC-087 protects Syrian hamsters against lethal challenge with human species C adenoviruses.

Authors:  Karoly Toth; Jacqueline F Spencer; Baoling Ying; Ann E Tollefson; Caroll B Hartline; Eric T Richard; Jiajun Fan; Jinglei Lyu; Boris A Kashemirov; Cheryl Harteg; Dawn Reyna; Elke Lipka; Mark N Prichard; Charles E McKenna; William S M Wold
Journal:  Antiviral Res       Date:  2018-03-03       Impact factor: 5.970

Review 5.  Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints.

Authors:  Hong Jiang; Candelaria Gomez-Manzano; Yisel Rivera-Molina; Frederick F Lang; Charles A Conrad; Juan Fueyo
Journal:  Curr Opin Virol       Date:  2015-04-13       Impact factor: 7.090

6.  Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

Authors:  Christopher J LaRocca; Joohee Han; Tatyana Gavrikova; Leonard Armstrong; Amanda R Oliveira; Ryan Shanley; Selwyn M Vickers; Masato Yamamoto; Julia Davydova
Journal:  Surgery       Date:  2015-02-27       Impact factor: 3.982

7.  Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.

Authors:  Pei-Hsin Cheng; Xiao-Mei Rao; Xiaoxian Duan; Xiao-Feng Li; Michael E Egger; Kelly M McMasters; H Sam Zhou
Journal:  J Mol Med (Berl)       Date:  2014-11-08       Impact factor: 4.599

8.  CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer.

Authors:  Samia M O'Bryan; J Michael Mathis
Journal:  J Cancer Ther       Date:  2021-06

9.  Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting.

Authors:  Mikko Siurala; Markus Vähä-Koskela; Riikka Havunen; Siri Tähtinen; Simona Bramante; Suvi Parviainen; J Michael Mathis; Anna Kanerva; Akseli Hemminki
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

10.  A survey on intestinal parasites of golden hamster (Mesocricetus auratus) in the northeast of Iran.

Authors:  Hassan Borji; Javad Khoshnegah; Gholamreza Razmi; Hossein Amini; Mahnaz Shariatzadeh
Journal:  J Parasit Dis       Date:  2013-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.